Mpm Oncology Impact Management Gp Llc - Net Worth and Insider Trading

Mpm Oncology Impact Management Gp Llc Net Worth

The estimated net worth of Mpm Oncology Impact Management Gp Llc is at least $506,390 dollars as of 2024-11-10. Mpm Oncology Impact Management Gp Llc is the 10% Owner of Sunesis Pharmaceuticals Inc and owns about 95,186 shares of Sunesis Pharmaceuticals Inc (SNSS) stock worth over $506,390. Details can be seen in Mpm Oncology Impact Management Gp Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mpm Oncology Impact Management Gp Llc has not made any transactions after 2017-11-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mpm Oncology Impact Management Gp Llc

To

Mpm Oncology Impact Management Gp Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mpm Oncology Impact Management Gp Llc owns 10 companies in total, including Oncorus Inc (ONCR) , ITeos Therapeutics Inc (ITOS) , and TCR2 Therapeutics Inc (TCRR) among others .

Click here to see the complete history of Mpm Oncology Impact Management Gp Llc’s form 4 insider trades.

Insider Ownership Summary of Mpm Oncology Impact Management Gp Llc

Ticker Comapny Transaction Date Type of Owner
ONCR Oncorus Inc 2020-10-01 10 percent owner
ITOS ITeos Therapeutics Inc 2020-07-23 other: X*
TCRR TCR2 Therapeutics Inc 2019-02-13 10 percent owner
LIMIT LIMIT 2019-02-07 10 percent owner
LIMIT LIMIT 2017-11-06 10 percent owner
LIMIT LIMIT 2017-03-25 10 percent owner
LIMIT LIMIT 2017-10-27 10 percent owner
LIMIT LIMIT 2017-03-25 10 percent owner
LIMIT LIMIT 2021-04-29 10 percent owner
LIMIT LIMIT 2021-01-07 10 percent owner

Mpm Oncology Impact Management Gp Llc Latest Holdings Summary

Mpm Oncology Impact Management Gp Llc currently owns a total of 1 stock. Mpm Oncology Impact Management Gp Llc owns 95,186 shares of Sunesis Pharmaceuticals Inc (SNSS) as of November 6, 2017, with a value of $506,390.

Latest Holdings of Mpm Oncology Impact Management Gp Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SNSS Sunesis Pharmaceuticals Inc 2017-11-06 95,186 5.32 506,390

Holding Weightings of Mpm Oncology Impact Management Gp Llc


Mpm Oncology Impact Management Gp Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Mpm Oncology Impact Management Gp Llc has made a total of 0 transactions in Sunesis Pharmaceuticals Inc (SNSS) over the past 5 years. The most-recent trade in Sunesis Pharmaceuticals Inc is the acquisition of 2,329 shares on November 6, 2017, which cost Mpm Oncology Impact Management Gp Llc around $225,755.

Insider Trading History of Mpm Oncology Impact Management Gp Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mpm Oncology Impact Management Gp Llc Trading Performance

GuruFocus tracks the stock performance after each of Mpm Oncology Impact Management Gp Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Oncology Impact Management Gp Llc is 105.15%. GuruFocus also compares Mpm Oncology Impact Management Gp Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Oncology Impact Management Gp Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mpm Oncology Impact Management Gp Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mpm Oncology Impact Management Gp Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -21.65 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -23.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Mpm Oncology Impact Management Gp Llc Ownership Network

Ownership Network List of Mpm Oncology Impact Management Gp Llc

No Data

Ownership Network Relation of Mpm Oncology Impact Management Gp Llc

Insider Network Chart

Mpm Oncology Impact Management Gp Llc Owned Company Details

What does Oncorus Inc do?

Who are the key executives at Oncorus Inc?

Mpm Oncology Impact Management Gp Llc is the 10 percent owner of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .

Oncorus Inc (ONCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oncorus Inc Insider Transactions

No Available Data

Mpm Oncology Impact Management Gp Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Mpm Oncology Impact Management Gp Llc. You might contact Mpm Oncology Impact Management Gp Llc via mailing address: 450 Kendall Street, Cambridge Ma 02142.